AssayIndex
SGN cross-section

SGN by compound

SGN records split by compound, with the index-wide comparison for the same compound beside each one. 26 compounds, 230 records. Cells below n=3 print their raw values instead of a median.

26 compounds230 records
CompoundClassReportsSGN median %Index median %Δ (pp)SpecPass %
TirzepatideIncretin3697.9498.44-0.5097.092
SemaglutideIncretin3298.0998.87-0.7897.0100
GHRP-6Growth-hormone2098.7199.65-0.9499.030
N-Acetyl Semax AmideNeuroactive2098.8999.26-0.3898.585
PT-141 (Bremelanotide)Melanocortin-receptor1998.3299.31-1.0098.516
BPC-157Tissue-repair1798.5599.15-0.6098.094
Melanotan IIMelanocortin-receptor1698.6299.24-0.6298.563
SLU-PP-332Non-peptide1298.2998.69-0.3998.075
CJC-1295 with DACGrowth-hormone898.4298.79-0.3797.5100
AfamelanotideMelanocortin-receptor6 n=698.4399.28-0.8598.067
TriptorelinHypothalamic6 n=698.4098.47-0.0698.533
SelankNeuroactive5 n=598.2999.13-0.8499.00
SermorelinGrowth-hormone5 n=598.7598.94-0.1998.0100
SS-31 (Elamipretide)Metabolic4 n=497.0799.42-2.3598.50
IGF-1 LR3Growth-hormone4 n=497.6497.75-0.1195.0100
MGFGrowth-hormone3 n=399.0698.73+0.3397.5100
CJC-1295 (no DAC)Growth-hormone3 n=398.2698.61-0.3598.067
Thymosin α1Tissue-repair2 n=2n<399.1197.5100
ARA-290Tissue-repair2 n=2n<399.4598.050
TB-500Tissue-repair2 n=2n<399.4798.5100
IpamorelinGrowth-hormone2 n=2n<399.4899.050
LiraglutideIncretin2 n=2n<399.0297.5100
GHK-CuTissue-repair1 n=1n<398.5497.0100
Kisspeptin-10Melanocortin-receptor1 n=1n<399.2798.50
EpitalonShort1 n=1n<398.6399.0100
L-Glutathione (reduced)Short1 n=1n<399.0098.5100
96.096.797.498.198.899.5100.2TirzepatideTirzepatide: Q1 97.53, median 97.94, Q3 98.45, n=36n=36SemaglutideSemaglutide: Q1 97.85, median 98.09, Q3 98.57, n=32outlier 99.79outlier 99.91n=32GHRP-6GHRP-6: Q1 98.45, median 98.71, Q3 99.05, n=20n=20N-Acetyl Semax AmideN-Acetyl Semax Amide: Q1 98.55, median 98.89, Q3 99.32, n=20outlier 97.31n=20PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 98.02, median 98.32, Q3 98.38, n=19outlier 99.25n=19BPC-157BPC-157: Q1 98.31, median 98.55, Q3 98.90, n=17n=17Melanotan IIMelanotan II: Q1 98.34, median 98.62, Q3 98.94, n=16outlier 96.85n=16SLU-PP-332SLU-PP-332: Q1 97.97, median 98.29, Q3 98.57, n=12n=12CJC-1295 with DACCJC-1295 with DAC: Q1 98.33, median 98.42, Q3 98.77, n=8n=8AfamelanotideAfamelanotide: Q1 98.01, median 98.43, Q3 98.83, n=6n=6TriptorelinTriptorelin: Q1 98.31, median 98.40, Q3 98.49, n=6outlier 98.01n=6SelankSelank: Q1 98.06, median 98.29, Q3 98.41, n=5outlier 97.50outlier 98.94n=5SermorelinSermorelin: Q1 98.37, median 98.75, Q3 99.05, n=5n=5SS-31 (Elamipretide)SS-31 (Elamipretide): Q1 96.86, median 97.07, Q3 97.28, n=4n=4 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.